Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
Yun Cai, Qiqi Xin, Jinjin Lu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 243
Berberine hydrochloride alleviates imatinib mesylate – induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis
Chengzhu Song, Dongning Li, Jie Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 2, pp. 1087-1098
Closed Access | Times Cited: 22
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
Jung Ho Han, Eun‐Ji Lee, Mi-Ju Park, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases
Zhifang Qin, Ran Tang, Juan Liang, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112422-112422
Closed Access | Times Cited: 12
Plant antibacterials: The challenges and opportunities
Tomayo Berida, Yemi A. Adekunle, Hannah Dada-Adegbola, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31145-e31145
Open Access | Times Cited: 8
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Zehua Liang, Yuquan He, Xin Hu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10617-10617
Open Access | Times Cited: 32
Diagnostic and Therapeutic Aptamers
Vittoria Di Mauro, Francesca Cecilia Lauta, Jessica Modica, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 260-277
Open Access | Times Cited: 18
Cardiovascular Effects of Herbal Products and Their Interaction with Antihypertensive Drugs—Comprehensive Review
Kinga-Ilona Nyulas, Zsuzsánna Simon-Szabó, Sándor Pál, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6388-6388
Open Access | Times Cited: 6
Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation
Ziyi Zhao, Jinhao Zeng, Qiang Guo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment
Rocco Mollace, Federica Scarano, Irene Bava, et al.
Pharmacological Research (2023) Vol. 196, pp. 106931-106931
Open Access | Times Cited: 15
Chinese herbal medicine for the treatment of cardiovascular diseases ─ Targeting cardiac ion channels
Zhenzhen Yan, Ling Zhong, Wandi Zhu, et al.
Pharmacological Research (2023) Vol. 192, pp. 106765-106765
Open Access | Times Cited: 14
Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties
Teruo Murakami, Erik T. Bodor, Nicholas Bodor
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 3, pp. 129-137
Closed Access | Times Cited: 13
Berberine Intervention Mitigates Myocardial Ischemia-Reperfusion Injury in a Rat Model: Mechanistic Insights via miR-184 Signaling
Haichen Yang, Gang Cao, Xia Li, et al.
Biologics (2025) Vol. Volume 19, pp. 31-42
Open Access
The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?
Abhipree Sharma, Michael Mah, Rebecca H. Ritchie, et al.
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108008-108008
Closed Access | Times Cited: 31
Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice
Zhichao Wang, Fang Wu, Qianbing Zhou, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 22
Berberine alleviates myocardial diastolic dysfunction by modulating Drp1-mediated mitochondrial fission and Ca2+ homeostasis in a murine model of HFpEF
Miyesaier Abudureyimu, Mingjie Yang, Xiang Wang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1219-1235
Closed Access | Times Cited: 11
Berberine alleviates diabetic retinopathy by regulating the Th17/Treg ratio
Yi Yang, Zexin Wen, Yanli Zhang, et al.
Immunology Letters (2024) Vol. 267, pp. 106862-106862
Closed Access | Times Cited: 3
Berberine ameliorates chronic intermittent hypoxia‐induced cardiac remodelling by preserving mitochondrial function, role of SIRT6 signalling
Zijun Zhou, Qiu-Sheng Zhao, Yuting Huang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 3
Natural Autophagy Activators to Fight Age-Related Diseases
Vianey M. Mundo Rivera, José Roberto Tlacuahuac Juárez, Nadia Mireya Murillo-Melo, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1611-1611
Open Access | Times Cited: 3
The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
Mohammad Zamani, Mahtab Zarei, Mahlagha Nikbaf‐Shandiz, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 14
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
Yafei Liu, Huanhuan Wang, Yin-Hong Geng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases
Peng Zhou, Yao-yao Ma, Xiao-ni Zhao, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 207-220
Closed Access | Times Cited: 7
Berberine Hydrochloride Improves Cognitive Function and Hippocampal Antioxidant Status in Subchronic and Chronic Lead Poisoning
Fatemeh Zare Mehrjerdi, Azadeh Shahrokhi Raeini, Fatemeh Sadate Zebhi, et al.
Chinese Journal of Integrative Medicine (2024)
Closed Access | Times Cited: 2
A prospective observational study to assess the cardiac risk factors and treatment patterns in established heart diseases
Palle Reddy, Golla Poojitha, Sandaram Kavitha, et al.
Cellular Molecular and Biomedical Reports (2022) Vol. 2, Iss. 4, pp. 265-275
Open Access | Times Cited: 12
Berberine attenuates sepsis‑induced cardiac dysfunction by upregulating the Akt/eNOS pathway in mice
Hong Zhang, Xiaofei Wu, Yanyan Tao, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top